Herbolea Overview
- Year Founded
-
2017
- Status
-
Private
- Employees
-
15
- Latest Deal Type
-
Series A
- Latest Deal Amount
-
$5.8M
- Investors
-
2
Herbolea General Information
Description
Developer of biotech extraction technology intended to focus on transforming botanicals into remedial products. The company's bio-refining platform generates products from therapeutic potential plants by envisioning the use of solventless extraction green technologies, concentrating and purifying bioactive compounds, enabling the healthcare sector to obtain safe, environmentally friendly, and low-cost natural products.
Contact Information
Website
www.herbolea.comCorporate Office
- Via Luciano Lama 9/11
- 50019 Sesto Fiorentino(Florence)
- Italy
Corporate Office
- Via Luciano Lama 9/11
- 50019 Sesto Fiorentino(Florence)
- Italy
Herbolea Valuation & Funding
| Deal Type | Date | Amount | Raised to Date | Post-Val | Status | Stage |
|---|---|---|---|---|---|---|
| 2. Early Stage VC (Series A) | 26-Oct-2021 | $5.8M | Completed | Generating Revenue | ||
| 1. Early Stage VC | 05-Mar-2019 | Completed | Generating Revenue |
VC Exit Predictor
See how our proprietary methodology utilizes historical data sets to synthesize the likelihood of an acquisition, IPO, or no exit event. Get a detailed look at the calculations behind our predictions.
Herbolea Patents
Herbolea Recent Patent Activity
| Publication ID | Patent Title | Status | First Filing Date | Technology (CPC) | Citations |
|---|---|---|---|---|---|
| WO-2025181258-A1 | Essential oil fraction, method of obtaining the same and use thereof | Pending | 27-Feb-2024 | ||
| AU-2023433961-A1 | Cannabinoid concentrate, method of obtaining the same and use thereof | Pending | 28-Feb-2023 | ||
| EP-4673434-A1 | Cannabinoid concentrate, method of obtaining the same and use thereof | Pending | 28-Feb-2023 | ||
| WO-2024179670-A1 | Cannabinoid concentrate, method of obtaining the same and use thereof | Inactive | 28-Feb-2023 | ||
| EP-4186374-A1 | Bitter acids concentrate, method of obtaining the same and use thereof | Pending | 24-Nov-2021 | A23L27/82 |
Herbolea Signals
Herbolea Investors (2)
| Investor Name | Investor Type | Holding | Investor Since | Participating Rounds |
|---|---|---|---|---|
| Óskare Capital | Venture Capital | Minority | ||
| AgMedica Bioscience | Corporation | Minority |
Herbolea Investments (1)
Herbolea’s most recent deal was a Later Stage VC with Agroils Technologies. The deal was made on 12-Aug-2024.
| Company Name | Deal Date | Deal Type | Deal Size | Industry | Lead Partner |
|---|---|---|---|---|---|
| Agroils Technologies | 12-Aug-2024 | Later Stage VC | Biotechnology |
Herbolea FAQs
-
When was Herbolea founded?
Herbolea was founded in 2017.
-
Where is Herbolea headquartered?
Herbolea is headquartered in Sesto Fiorentino, Italy.
-
What is the size of Herbolea?
Herbolea has 15 total employees.
-
What industry is Herbolea in?
Herbolea’s primary industry is Biotechnology.
-
Is Herbolea a private or public company?
Herbolea is a Private company.
-
What is Herbolea’s current revenue?
The current revenue for Herbolea is .
-
How much funding has Herbolea raised over time?
Herbolea has raised $5.8M.
-
Who are Herbolea’s investors?
Óskare Capital and AgMedica Bioscience have invested in Herbolea.
Data Transparency
-
Meet our data hygiene team
Discover how our experts ensure you’re getting the most accurate financial data in the industry.
Read more -
How PitchBook sources data
Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.
Discover our process